1298 related articles for article (PubMed ID: 22654421)
1. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Soejima Y; Fukusato T
World J Gastroenterol; 2012 May; 18(19):2300-8. PubMed ID: 22654421
[TBL] [Abstract][Full Text] [Related]
2. Lessons from mouse models of high-fat diet-induced NAFLD.
Nakamura A; Terauchi Y
Int J Mol Sci; 2013 Oct; 14(11):21240-57. PubMed ID: 24284392
[TBL] [Abstract][Full Text] [Related]
3. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
4. Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology.
Takahashi Y; Fukusato T
World J Gastroenterol; 2010 Nov; 16(42):5280-5. PubMed ID: 21072890
[TBL] [Abstract][Full Text] [Related]
5. Animal models of nonalcoholic fatty liver disease.
Hebbard L; George J
Nat Rev Gastroenterol Hepatol; 2011 Jan; 8(1):35-44. PubMed ID: 21119613
[TBL] [Abstract][Full Text] [Related]
6. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Kramer JA; Grindley J; Crowell AM; Makaron L; Kohli R; Kirby M; Mansfield KG; Wachtman LM
Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270
[TBL] [Abstract][Full Text] [Related]
7. Rodent Models of Nonalcoholic Fatty Liver Disease.
Zhong F; Zhou X; Xu J; Gao L
Digestion; 2020; 101(5):522-535. PubMed ID: 31600750
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
9. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
10. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice.
Czech B; Neumann ID; Müller M; Reber SO; Hellerbrand C
Int J Clin Exp Pathol; 2013; 6(8):1585-93. PubMed ID: 23923077
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified mouse models for the study of nonalcoholic fatty liver disease.
Nagarajan P; Mahesh Kumar MJ; Venkatesan R; Majundar SS; Juyal RC
World J Gastroenterol; 2012 Mar; 18(11):1141-53. PubMed ID: 22468076
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome.
Nishida T; Tsuneyama K; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Nakanishi Y; Sasaki Y; Suzuki W; Iizuka S; Nagata M; Shimada T; Aburada M; Shimada Y; Imura J
Lab Invest; 2013 Feb; 93(2):230-41. PubMed ID: 23212097
[TBL] [Abstract][Full Text] [Related]
14. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
[TBL] [Abstract][Full Text] [Related]
15. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
Kim SK; Kim KI; Kim SR
Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
[TBL] [Abstract][Full Text] [Related]
16. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
17. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Wu J
Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of and major animal models used for nonalcoholic fatty liver disease.
Jiang M; Wu N; Chen X; Wang W; Chu Y; Liu H; Li W; Chen D; Li X; Xu B
J Int Med Res; 2019 Apr; 47(4):1453-1466. PubMed ID: 30871397
[TBL] [Abstract][Full Text] [Related]
19. Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease.
Radwan MM; Radwan BM; Nandipati KC; Hunter WJ; Agrawal DK
Expert Rev Clin Immunol; 2013 Aug; 9(8):727-38. PubMed ID: 23971751
[TBL] [Abstract][Full Text] [Related]
20. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Brown GT; Kleiner DE
Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
